Insulin resistance during pregnancy is counteracted by enhanced insulin secretion. This condition is aggravated by obesity, which increases the risk of gestational diabetes. Therefore, pancreatic islet functionality was investigated in control non-pregnant (C) and pregnant (CP), and cafeteria diet fed non-pregnant (Caf) and pregnant (CafP) obese rats. Isolated islets were used for measurements of insulin secretion (RIA); NAD(P)H production (MTS); glucose oxidation ( 14 CO 2 production); intracellular Ca 2+ levels (Fura-2 AM); and gene expression (Real-Time PCR). Impaired glucose tolerance was clearly established in Caf and CafP rats at the 14 th week on diet. Insulin secretion induced by direct depolarizing agents such as KCl and tolbutamide and increasing concentrations of glucose was significantly reduced in Caf, compared to C islets. This reduction was not observed in islets from CP and CafP rats.
Introduction
Pregnancy is associated with peripheral insulin resistance, which is compensated by increased insulin secretion during normal circumstances (3, 19, 30 ). Pancreatic islets undergo major structural and functional changes during pregnancy to fulfil this increased demand for insulin (1, 30, 34) . These alterations in rats, peak at around days 14-16 of pregnancy, and the placental lactogens and/or prolactin hormones play an important role in this process (6, 8, 23, 33 ).
The mechanisms responsible for increasing the capacity of the beta cells to respond to a higher demand of insulin during pregnancy is very relevant in the context of Type 2 diabetes studies, since it may provide clues for potential therapeutics. The inability of maternal beta-cells to respond to this increased demand for insulin can lead to the development of glucose intolerance and to gestational diabetes mellitus (10, 11) .
Several models of experimental obesity have been used to date. Among them, the use of the fat-rich diet is an interesting approach, since it closely resembles the overfeeding intake of humans, affecting specific tissues involved in the regulation of energy expenditure (9, 36 ). An improvement for this model is the use of the cafeteria diet, which is even closer to human food intake, since it is more palatable, strongly increases adiposity, and has been proposed to be the rodent model that best fits human obesity (25, 27, 28) .
In this study, we investigated glucose homeostasis and pancreatic islet functionality in nonpregnant and pregnant cafeteria diet-induced obese rats. We found that glucose tolerance is impaired in obese cafeteria-fed pregnant and non-pregnant rats. Cafeteria diet-induced obesity impairs insulin secretion induced by glucose, tolbutamide and KCl in freshly-isolated islets.
However, this inhibitory effect is overcome in islets from pregnant rats, probably as a result of an increase in metabolic activity, associated with a better intracellular Ca 2+ handling, in especial Ca 2+ influx.
from proteins, and 46.9 % from fats) as opposed to the 2.63 kcal/g of the standard chow diet Nuvilab CR-1 (NUVITAL TM , Colombo, PR, Brazil). To guarantee the success of this protocol, leftovers were collected and replaced with new items daily. During the feeding period, rats' weight gain was measured weekly. After 12 weeks of treatment, the rats were mated by housing males with females overnight during three days, and the presence of sperm in vaginal smears was verified each morning. On the occasion of presence of sperm (day one of pregnancy), the female rat was housed separately for confirmation of pregnancy and further utilized in experiments on the 15 th /16 th day of pregnancy, corresponding the 14 th week of treatment. During the experimental period, rats were housed at 22 ± 2 ºC on a 12 h light/dark cycle (lights on 06:00 -18:00 h).
Animal features
At the end of the feeding period, and on the 15 th /16 th day of pregnancy, the rats were killed by decapitation, and perigonadal and retroperitoneal fat pad weights were measured. Blood glucose levels were measured using a Glucose Analyzer (Accu-Check Advantage II, Roche, Basel, Switzerland). Plasma CHOL, TG, FFA, albumin and total proteins were measured using standard commercial kits, according to the manufacturer's instructions. Insulin was measured by radioimmunoassay (RIA) using rat insulin as standard.
Intraperitoneal Glucose Tolerance Test (ipGTT)
At 14-15 days after the onset of pregnancy, all groups of rats were submitted to an ipGTT.
Food was withdrawn 12 h before the experiment, then the rats were weighed and a basal blood sample was taken from the tip of the tail (t = 0 min with bovine serum albumin (0.3 % w/v; Sigma). For measurement of the total insulin content, groups of 10 islets were collected and transferred to tubes of 1.5 ml. Alcohol-acid solution (1 mL; final concentration of 20 % of ethanol and 0.2 mmol/L of HCl) was added to the samples followed by sonication of the pancreatic islets (3 times, 10 s pulses). The insulin in the media was measured by RIA.
DNA assay
Pancreatic islets were homogenized through short bursts of sonication in 500 μl buffer composed of 50 mmol/L Tris-HCl, 10 mM EDTA, 1% SDS (pH 8.1). DNA was extracted in phenol/chloroform, precipitated in ethanol, and resuspended in low TE buffer. RNA was subsequently removed by digestion with 1 μg of RNAse A (Sigma) for 30 min at 37ºC. Thus, DNA was quantified using a commercial kit (Quant-iT™ PicoGreen, Invitrogen) according to the instructions in the manual.
Glucose oxidation
Groups of 25 islets were incubated for 2 h at 37 ºC in KRB supplemented with 11.1 mmol/L glucose with trace amounts of D-[U-14 C]glucose (20 μCi/mL) for 14 CO 2 formation. Islet glucose metabolism was stopped with HCl (1 N) with consequent cell cleavage. 14 CO 2 released was absorbed by NaOH (1 mol/L) for 1 h at 4 ºC, obtaining NaH 14 CO 3 . Scintillation fluid was added and radioactivity was counted in a liquid scintillation counter.
Metabolic activity
Metabolic activity of islets was assessed by measuring reducing equivalents, namely NAD(P)H, through reduction of a water-soluble tetrazolium salt, MTS (3- 
Measurement of intracellular Ca

2+
Freshly-isolated islets were incubated in RPMI 1640 medium supplemented with 5 % foetal calf serum, 11.1 mmol/L glucose, 100 UI of penicillin/mL, 100 μg of streptomycin/mL at 37 (F340/F380) at least two times greater than any change in F340/F380 at basal glucose concentration. The frequency was calculated by counting the number of oscillations during 11.1 mmol/L glucose and it was expressed as oscillations per min. In the experiments with tolbutamide, the area under the curves was calculated during the period that the drug was present in the medium, after subtracting the basal values (2.8 mmol/L glucose).
Real-time PCR
Total cellular RNA was extracted from groups of 500 islets using Trizol reagent. Two micrograms of total RNA was reverse transcribed using a reverse transcriptase and random hexamer primers. Real time PCR reactions were performed in a total volume of 15 µL using the Fast SYBR Green technology (Applied Biosystems, Foster City, CA). Samples were denatured at 94 °C for 10 min followed by 40 PCR cycles at 95 °C/60 °C. PCR amplifications were performed in duplicate. The purity of the amplified PCR products was verified by melting curves. The expression of the target genes were normalized against the expression levels of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Sequence of the primers used were (5' -3'): sarco/endoplasmic reticulum Ca 2+ ATPase 2a
Statistical analysis
Data were expressed as means ± SE for the number of rats and samples (n) indicated.
Statistical analysis was performed by the Student's t test or two-way ANOVA, followed by the Newman-Keuls post-test. P < 0.05 was considered statistically significant.
Results
Animal features
Cafeteria-diet-fed rats showed a greater weight gain than control chow-diet-fed rats from the 3 rd until the 12 st week of the feeding period, when females were mated with males ( Fig. 1 ). At the end of the diet period (14 th week), body weight, retroperitoneal and perigonadal fat pad weights were heavier in Caf and CafP rats, compared with the C and CP groups (Table 1) .
CafP and CP rats presented higher body weight than Caf and C rats, respectively, due to the contribution of the weight of foetuses. After 12 h of fasting, plasma insulin, TG, FFA, albumin and total plasma protein levels were similar for the groups (Table 2) . Fasting blood glucose and plasma CHOL) levels were lower in CP and CafP than the C and Caf groups. In the fed state, plasma insulin and FFA levels were higher in Caf and CafP than C and CP rats.
Fed blood glucose levels were diminished in both CP and CafP rats, compared to nonpregnant groups. In CP rats, fed TG plasma levels were higher than those of the C group.
CHOL, albumin and total plasma proteins values were similar in the groups during the fed state. Insulin/glucose index was higher in Caf and CafP than C and CP groups in both fasting (12 h) and fed conditions.
Glucose tolerance
As installation of insulin resistance in diet-induced obesity is time-dependent and tissuespecific (25), our first studies were performed in rats fed on a cafeteria diet for 8 week. After this period, we observed an increase in weight gain, but only a marginal impairment in glucose tolerance in the cafeteria-diet-fed rats (data not shown) and, for this reason, we decided to extend the diet period for 6 additional weeks. After 14 weeks, cafeteria-dietinduced obesity provoked impaired glucose tolerance in pregnant and non-pregnant rats ( Fig.   2A ). This effect was dependent only on obesity, rather than on the pregnancy state or on the interaction between both conditions. At 30 min after glucose challenge, blood glucose concentrations were higher in Caf (vs C rats; P < 0.05) and in CafP (vs C and CP rats; P < 0.05). After 1 h, glycaemia was still higher in Caf and CafP rats, compared with C and CP rats ( Fig. 2A) . The area under the curve in response to glucose load was higher in Caf and
CafP than in control groups [32,370 ± 1,680 Caf (n=19), 31,280 ± 3,015 CafP (n=6) vs 22,800 ± 1,095 C (n=18), 20,500 ± 885 CP (n=6), respectively; mg/dL.min -1 ] (P < 0.01). This effect, at least in the CafP rats, was probably due to an increase in insulin resistance, since plasma insulin during the GTT (Fig. 2B) in CafP rats at 15 min (interaction among obesity and pregnancy) and 1 h (effect of obesity) was higher than that of the other groups.
Islet insulin content, and insulin secretion induced by glucose, KCl, and Tolbutamide
Pregnancy enhanced total insulin content in islets from CafP rats compared with the other groups (43.7 ± 3.7 vs C 15.6 ± 1.2; CP 19.1 ± 1.5; Caf 12.6 ± 1.1, ng/ng DNA P < 0.001; n = 14-19). This effect was dependent on both obesity and the pregnancy states and also on the interaction between both conditions. Total insulin content was similar in C, CP, and Caf islets. The insulin released by islets during static incubation in response to increasing glucose concentrations (2.8 -27.7 mmol/L), normalized by the islet DNA content, is shown in Figure   3 . In all groups, insulin secretion was represented by a sigmoidal curve. At 2.8 mmol/L glucose, insulin released was higher in Caf and CafP compared with C and CP islets (P < 0.05). At 5.6 mmol/L glucose, secretion was higher in islets from pregnant (CP and CafP)
than non-pregnant rats (C and Caf) (P < 0.05). The insulin secretion, in the presence of 8.3 mmol/L glucose, was lower in Caf compared with CP and CafP groups (P < 0.01). At 11.1 mmol/L glucose, the insulin secretion was significantly lower in Caf compared with C, CP,
and CafP islets (P < 0.05). Finally, at 16.7 mmol/L glucose, but not at 27.7 mmol/L, insulin secretion was higher in CafP than Caf islets (P < 0.05). Pregnancy shifted the dose-response curve to the left in both chow (CP) and cafeteria diet (CafP), compared with non-pregnant rats (C and Caf groups). When the insulin secretion was expressed as a percent of the maximal release inside each group (inset of Fig. 3) , the half-maximal release (EC 50 ) was higher in Caf compared with other groups (12.3 ± 0.6, 10.6 ± 0.2, 9.3 ± 0.1 and 9.6 ± 0.5 mmol/L, respectively for Caf, C, CP and CafP; P < 0.05). It is of note that normalization of insulin secretion by total insulin content shifted the glucose dose-response curve to the right in the CafP group (not shown). However, it seems that this kind of normalization does not reflect the capacity of individual islets to secrete insulin, as judged by the results normalized to total DNA content. Insulin secretion stimulated by 40 mmol/L KCl or 100 µmol/L tolbutamide, in the presence of 2.8 mmol/L glucose, was strongly reduced in Caf islets compared with all the other groups, and higher in CafP than CP islets (P < 0.05; n=8-10) (Fig. 4) . These results indicate that Caf islets also secreted less insulin than the other groups when the islet cells were depolarized by agents that bypass nutrient metabolism, and that pregnancy restores insulin secretion in those experimental conditions.
Glucose oxidation and metabolic activity
Since insulin secretion from beta-cells is closely linked to metabolism of glucose, we analyzed some metabolic indicators in islets from obese and pregnant rats. At 11.1 mmol/L glucose, the D-[U-14 C]glucose conversion to 14 CO 2 (glucose oxidation) was higher in islets from CafP rats, compared with the other groups (CafP 2.9 ± 0.1 vs C 2.1 ± 0.2; CP 2.0 ± 0.1, and Caf 1.9 ± 0.1 pmol/ngDNA.2h; P < 0.001; n = 12). This effect was dependent on both obesity and the pregnancy state and also on the interaction between both conditions. We also measured the generation of reducing equivalents [i.e. NAD(P)H)] in the presence of 11.1 mmol/L glucose, as an indicator of the metabolic activity of the islets (33). CafP showed a higher metabolic activity compared to C and CP islets already at 10 min, and this activity was higher compared to all other groups from 30 up to 150 min (effect of both obesity and pregnancy with interaction) (Fig. 5) . It is of note that CP also showed higher glucose oxidation and metabolic activity compared to C group in absolute values, a difference not seem after normalization to total DNA content (not shown).
Glucose-and tolbutamide-induced cytoplasmic Ca 2+ alterations
After exposure of pancreatic islets to 11.1 mmol/L glucose, cytosolic Ca 2+ concentrations were increased in all groups ( Fig. 6 ; A, B, C and D). The amplitude of the Ca 2+ alterations, measured after 3-6 min glucose exposure, was significantly lower in islets from Caf, compared with the other 3 groups (Fig. 6E) (P < 0.05; with interaction among obesity and pregnancy). The frequency of oscillations was similar between islets from C and Caf and increased significantly in islets from both CP and CafP groups (Fig. 6F) (P < 0.05). Finally, the amplitude of the oscillations was higher in CafP, compared with Caf islets (P < 0.05).
The cytosolic Ca 2+ concentrations were also increased by tolbutamide (100 µmol/L) in all groups, and the area under the curve was lower in Caf compared with C islets (0.72 ± 0.14 vs 1.20 ± 0.10 F340/F380.min; P < 0.05; n=6), an effect of obesity without interaction.
Ca v α1.2, Ca v β2 and SERCA2a gene expression
A reduction of both Ca v α1.2 (64 % vs C; P < 0.01) and SERCA2a (27 % vs C; P < 0.05) gene expression was observed in Caf compared to C islets ( Fig. 7A and C) . Pregnancy enhanced both Ca v α1.2 (56 % vs C; P < 0.05) and SERCA2a (27 % vs C; P < 0.05) islet gene expression in control rats ( Fig. 7A and C) . Ca v α1.2 gene expression was augmented in CafP compared to Caf islets (77 % vs Caf; P < 0.001), while no differences were found in SERCA2a between these groups. These results showed separated effects of obesity and pregnancy (without interaction) in SERCA2a gene expression, while in Ca v α1.2 gene expression there was an effect of both nutritional and physiological conditions with interaction. Ca v β 2 gene expression was similar among the groups (Fig. 7B ).
Discussion
Obesity is reaching epidemic proportions worldwide, mainly due to changes in life style and easy access to both imbalanced food and overfeeding (7). Many diseases are associated with or have increased risks for health in obese patients, including Type 2 diabetes (4, 13). Under normal situations, the organism is able to compensate the demand for insulin, increasing the hormone secretion from pancreatic beta-cells (24) . Defects or inability of the beta-cells to respond to glucose certainly have a role in the onset of Type 2 diabetes. Therefore, the mechanisms that make beta-cells capable of overcoming insulin resistance during pregnancy are of great importance within the scope of biomedical sciences, having potential implications for humans. To address this question, we used an experimental model where obesity was achieved by feeding female rats on a high-fat/high-calorie cafeteria diet (25, 35). Since the metabolic disorders induced by the cafeteria diet closely resemble those observed in humans,
this is an attractive model to study obesity and also its consequence upon pregnancy. Our results show that cafeteria-induced obesity impairs insulin secretion stimulated by glucose and also by direct depolarizing agents, which is ameliorated in obese rats during pregnancy, and point to an important role of increased metabolic activity and especially of Ca 2+ influx and mobilization in this process.
The impaired glucose tolerance observed in obese rats, both pregnant and non-pregnant, is in accordance with several observations showing that obesity induces insulin resistance (4, 16, 22, 25) . Interestingly, fasted and fed plasma glucose is normal in the insulin-resistant rats, especially in pregnant groups, indicating that the higher plasma insulin levels are enough to maintain normoglycaemia. The resistance to endogenous insulin in rats develops between days 16 and 19 of pregnancy (18), justifying the normal insulin levels observed in the pregnant chow-diet rats during ipGTT at the 14-15 th day of pregnancy.
Reductions in insulin secretion stimulated by glucose in islets from rats fed on high carbohydrate, high protein or high lipid diets have been previously observed (31). Thus, it is expected that obese cafeteria rats also present lower insulin release capacity. Nevertheless, the recovery of this capacity during pregnancy is of crucial interest and the information regarding intracellular events leading to this enhanced insulin secretion is not yet known. Therefore, our
results showing increased metabolic activity, improved Ca 2+ handling, and recovery of insulin secretion in pancreatic beta-cells of obese rats during pregnancy are, to our knowledge, the first data to contribute to the clarification of the molecular mechanism of this phenomenon.
On the other hand, it is at variance with decreased insulin secretion observed in high saturated-fat fed pregnant obese rats (15) . We understand that different findings may be the outcome of different scientific strategies (type and time of diet, and time of pregnancy), but it is clear that cafeteria-diet is much closer to human overfeeding than other experimental models.
It is well established that the redox signaling is important for normal cellular functions and it is of the greatest importance in the case of beta-cells, where the oxidative metabolism is the main signal for insulin secretion. The majority of the NADPH inside the cells comes from the pentose phosphate pathway owning to the oxidative phase of reactions. At the molecular levels, NADPH can be generated by mitochondrial transhydrogenase or in the cytosol from glucose-6-phosphate by several enzymes (37) . It has been known since long ago that intracellular NADPH increases following a load of glucose on pancreatic islets, and it is assumed that the increase in the ratio of [NADPH / NADP+] is important for insulin secretion (14, 20) . Conversely, the [NADH / NAD+] ratio seems to be of no importance for proper insulin secretion (14). Recently it has been proposed that NADPH is important for Ca 2+ homeostasis (37) . Indeed, NADPH is essential for Ca 2+ -induced insulin exocytosis, an effect that seems to be mediate by the NADPH-dependent protein glutaredoxin-1 (26). Therefore, the increase in NADPH showed in this study, may partly explain the recovery of the insulin secretion capacity of pregnant obese rats. We speculate that a possible increase in the nonoxidative phase of pentose phosphate pathway may also provide additional substrate (fructose-6-phosphate) to glycolysis. This hypothesis is in line with the increase in glucose oxidation in pregnant obese rats, albeit it cannot be excluded by our data that these pathways are independently regulated.
Several of the steps involved in the insulin secretion process are modulated during pregnancy (1, 5, 8, 30) . Ca 2+ has a multitude of effects on the cells, and plays an essential role on exocytosis (12 (21), a defect linked to alterations in the activity and expression of the SERCA, which is involved in the regulation of Ca 2+ handling by beta-cells (17, 21) . Actually, pregnancy increases SERCA2 protein expression in pancreatic islets, as shown in this study, and the inhibition of this protein decreases the first phase of insulin secretion, suggesting that intracellular Ca 2+ stores in pancreatic islets from pregnant rats play a role in the enhancement of insulin release capacity (2). It seems that normalization of the Ca v α1.2 gene expression in CafP islets is sufficient to restore cytoplasmic Ca 2+ levels and insulin secretion in these islets, independent of modifications on the SERCA2a expression.
Perspectives and Significance
The present observations indicate that cafeteria-diet induces obesity, insulin resistance, and diminish insulin secretion stimulated by glucose and other depolarizing agents. The inhibitory effect of obesity on insulin secretion seems to be due to a defect in Ca 2+ mobilization by these islets, independently of alterations in islets metabolism. Pregnancy recover the secretory capacity in islets from obese rats which is linked to the restoration of the beta-cell ability to Table Legends   Table 1 C -non-pregnant chow diet; CP -pregnant chow diet; Caf -non-pregnant cafeteria diet;
CafP -pregnant cafeteria diet. Values are means ± SE; n= 6-8 rats, triplicates from three different and independent treatments. * P < 0.05 *** P < 0.001.
Table 2
Values are means ± SE; (n) from three different treatment groups.
1 P < 0.05; different from C and CP; 2 P < 0.01; different from C; 3 P < 0.05; different from C and Caf; 4 P < 0.01; different from all other groups. 
